Defined Suspension Medium for Tumor Cell Clusters
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for culturing primary cancer cells in three-dimensional matrix-embedded systems are not optimized, leading to low viability, contamination, and difficulty in reproducing results, making it challenging to effectively evaluate chemosensitivity and develop targeted therapies for cancer.
Innovation Solution
A defined medium suspension system that supports the proliferation of human tumor cell clusters from patients, comprising specific components such as DMEM/F-12, Wnt3A, bFGF, insulin, and other growth factors, allowing for efficient culture of tumor cells in suspension without an extracellular matrix, enabling rapid evaluation of therapeutic agent responsiveness.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If matrix-embedded three-dimensional cultures are used to culture primary cancer cells, then the cultural model better reflects in vivo conditions, but the conditions are not optimized leading to low cell viability and contamination
Solution Approach 1:
The patent extracts the essential growth factors and nutrients from complex matrix-embedded systems and formulates them into a defined suspension culture medium. This removes the matrix component that causes contamination and optimization difficulties while retaining the critical biochemical signals needed for cell viability, thereby simplifying the system without sacrificing reliability
Solution Approach 2:
The patent optimizes specific parameters of the culture medium including concentrations of growth factors (EGF, bFGF, IGF-1), serum replacement components, and pH buffering systems. By systematically adjusting these parameters in suspension culture conditions, the patent achieves high cell viability without requiring complex matrix embedding
2Adaptability or versatility
If primary cultures of cancer cells are established, then patient-specific tumor models are obtained, but the process is laborious and results are difficult to reproduce
Solution Approach 1:
The patent creates simplified copies of the in vivo tumor microenvironment through defined suspension culture conditions that replicate essential growth signals without requiring complex matrix embedding. This allows patient-specific cells to be cultured using standardized protocols that are easy to reproduce across different laboratories while maintaining patient-specific tumor characteristics
Solution Approach 2:
The patent performs preliminary optimization of the suspension culture medium formulation and conditions before applying them to patient samples. This pre-established optimized protocol eliminates the need for laborious trial-and-error optimization for each new patient sample, making the process straightforward and highly reproducible
3Productivity
If traditional culture methods are used, then established protocols are available, but the time required for chemosensitivity evaluation is excessive
Solution Approach 1:
The patent uses suspension culture conditions that enable rapid cell proliferation and early visible growth within 7-14 days, skipping the extended adaptation period required by traditional adherent culture methods. This accelerated growth kinetics allows chemosensitivity evaluation to be completed much faster without sacrificing accuracy
Data Source
AI summary
Provided are suspension-based cell culture systems and media for the timely and efficient proliferation of human tumor cell clusters from a patient, and related methods of evaluating the potential responsiveness of the tumor cells and the patient to one or more therapeutic agents.